Abstract
Background:
Data on genotype-phenotype correlation in children is limited. Hence, we studied the prevalence of germline mutations and genotype-phenotype correlation in children with pheochromocytoma (PCC)/paraganglioma (PGL) and compared it with adult PCC/PGL cohort.
Methods:
A total of 121 consecutive, unrelated, index PCC/PGL patients underwent genetic testing for five PCC/PGL susceptibility genes (RET, VHL, SDHB, SDHD and SDHC) and were evaluated for clinical diagnosis of neurofibromatosis type1 (NF1).
Results:
Thirty patients (12 boys, 18 girls) presented at ≤20 years of age (mean age of 15.9±3.8 years). Children were more frequently symptomatic and more frequently had bilateral PCC than adults. Fourteen (46.7%) PCC/PGL children had germline mutations (VHL 10 [33.3%], SDHB 2 [6.6%], and SDHD 2 [6.6%]). Overall germline mutations (46.7% vs. 26.4%, p=0.04) and VHL mutations (33.3% vs. 10.9%, p=0.026) were significantly more common in children than in adults. In children with VHL mutations, bilateral PCC were more frequent than in adults with VHL mutations. Within the paediatric cohort, bilateral PCC (60% vs. 5%, p=0.002), PCC+sPGL (30% vs. 0%, p=0.03) and occurrence of a second PCC/PGL (30% vs. 0%, p=0.03) were significantly more frequent among children with VHL mutations than others.
Conclusions:
All PCC/PGL children should be screened for germline mutations with first priority for VHL gene testing. Paediatric PCC/PGL patients with VHL mutations should be thoroughly evaluated for bilateral PCC and PCC+sPGL at initial presentation and closely followed up for occurrence of a second PCC/PGL.
Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.
Research funding: This project has been funded by the Scientific and Engineering Research Board (SERB), Department of Science and Technology, Government of India (Grant# SB/SO/HS-41/2013).
Employment or leadership: None declared.
Honorarium: None declared.
Competing interests: The funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
References
1. Ein SH, Pullerits J, Creighton R, Balfe JW. Pediatric phaeochromocytoma: a 36-year review. Pediatr Surg Int 1997;12:595–8.10.1007/BF01371907Search in Google Scholar PubMed
2. Wyszyńska T, Cichocka E, Wieteska-Klimczak A, Jobs K, Januszewicz P. A single pediatric center experience with 1025 children with hypertension. Acta Paediatr 1992;81:244–6.10.1111/j.1651-2227.1992.tb12213.xSearch in Google Scholar PubMed
3. Pham TH, Moir C, Thompson GB, Zarroug AE, Hamner CE, et al. Phaeochromocytoma and paraganglioma in children: a review of medical and surgical management at a tertiary care centre. Pediatrics 2006;118:1109–17.10.1542/peds.2005-2299Search in Google Scholar PubMed
4. Havekes B, Romijn JA, Eisenhofer G, Adams K, Pacak K. Update on pediatric pheochromocytoma. Pediatr 2009;24:943–50.10.1007/s00467-008-0888-9Search in Google Scholar PubMed
5. Waguespack SG, Rich T, Grubbs E, Ying AK, Perrier ND, et al. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2010;95:2023–37.10.1210/jc.2009-2830Search in Google Scholar PubMed
6. Castro-Vega LJ, Lepoutre-Lussey C, Gimenez-Roqueplo AP, Favier J. Rethinking pheochromocytomas and paragangliomas from a genomic perspective. Oncogene 2016;35:1080–9.10.1038/onc.2015.172Search in Google Scholar PubMed
7. Amar L, Bertherat J, Baudin E, Ajzenberg C, Bressac-de Paillerets B, et al. Genetic testing in pheochromocytoma or functional paraganglioma. J Clin Oncol 2005;23:8812–8.10.1200/JCO.2005.03.1484Search in Google Scholar PubMed
8. Cascón A, Pita G, Burnichon N, Landa I, López-Jiménez E, et al. Genetics of pheochromocytoma and paraganglioma in Spanish patients. J Clin Endocrinol Metab 2009;94:1701–5.10.1210/jc.2008-2756Search in Google Scholar PubMed
9. Mannelli M, Castellano M, Schiavi F, Filetti S, Giacchè M, et al. Italian pheochromocytoma/paraganglioma Network. Clinically guided genetic screening in a large cohort of italian patients with pheochromocytomas and/or functional or non functional paragangliomas. J Clin Endocrinol Metab 2009;94:1541–7.10.1210/jc.2008-2419Search in Google Scholar PubMed
10. Neumann HP, Bausch B, McWhinney SR, Bender BU, Gimm O, et al. Freiburg-Warsaw-Columbus Pheochromocytoma Study Group. Germ-line mutations in nonsyndromic pheochromocytoma. N Engl J Med 2002;346:1459–66.10.1056/NEJMoa020152Search in Google Scholar PubMed
11. Cascón I, de Cubas AA, Letón R, Mora J, Marazuela M, et al. Genetics of pheochromocytoma and paraganglioma in Spanish pediatric patients. Endocr Relat Cancer 2013;20:L1–6.10.1530/ERC-12-0339Search in Google Scholar PubMed
12. Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, et al. Long term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer 2013;21:17–25.10.1530/ERC-13-0415Search in Google Scholar PubMed
13. Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab 2009;94:4757–67.10.1210/jc.2009-1248Search in Google Scholar PubMed PubMed Central
14. Janssen I, Blanchet EM, Adams K, Chen CC, Millo CM, et al. Superiority of [68Ga]-DOTATATE PET/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma. Clin Cancer Res 2015;21:3888–95.10.1158/1078-0432.CCR-14-2751Search in Google Scholar PubMed PubMed Central
15. Gimenez-Roqueplo AP, Favier J, Rustin P, Rieubland C, Crespin M, et al. Mutations in the SDHB gene are associated with extra-adrenal and/or malignant phaeochromocytomas. Cancer Res 2003;63:5615–21.Search in Google Scholar
16. Castinetti F, Taieb D, Henry JF, Walz M, Guerin C, et al. Management of endocrine disease: outcome of adrenal sparing surgery in heritable pheochromocytoma. Eur J Endocrinol 2016;174:R9–18.10.1530/EJE-15-0549Search in Google Scholar PubMed
17. Pandit R, Khadilkar K, Sarathi V, Kasaliwal R, Goroshi M, et al. Germline mutations and genotype– phenotype correlation in Asian Indian patients with pheochromocytoma and paraganglioma. Eur J Endocrinol 2016;4:1–13.Search in Google Scholar
18. National Institutes of Health Consensus Development Conference Statement: neurofibromatosis. Bethesda, Md., USA, July 13–15, 1987. Neurofibromatosis 1988;1:172–8.Search in Google Scholar
19. Khadilkar K, Sarathi V, Kasaliwal R, Pandit R, Goroshi M, et al. Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience. Endocr Connect 2016;5:89–97.10.1530/EC-16-0086Search in Google Scholar PubMed PubMed Central
20. De Krijger RR, Petri BJ, Van Nederveen FH, Korpershoek E, De Herder WW, et al. Frequent genetic changes in childhood pheochromocytomas. Ann N Y Acad Sci 2006;1073:166–76.10.1196/annals.1353.017Search in Google Scholar PubMed
21. Barontini M, Levin G, Sanso G. Characteristics of pheochromocytoma in a 4- to 20-year-old population. Ann N Y Acad Sci 2006;1073:30–7.10.1196/annals.1353.003Search in Google Scholar PubMed
22. Hammond PJ, Murphy D, Carachi R, Davidson DF, McIntosh D. Childhood phaeochromocytoma and paraganglioma: 100% incidence of genetic mutations and 100% survival. J Pediatr Surg 2010;45:383–6.10.1016/j.jpedsurg.2009.10.082Search in Google Scholar PubMed
23. Beltsevich DG, Kuznetsov NS, Kazaryan AM, Lysenko MA. Pheochromocytoma surgery: epidemiologic peculiarities in children. World J Surg 2004;28:592–6.10.1007/s00268-004-7134-9Search in Google Scholar PubMed
24. Reddy VS, O’Neill JA Jr, Holcomb GW 3rd, Neblett WW 3rd, Pietsch JB, et al. Twenty-five-year surgical experience with pheochromocytoma in children. Am Surg 2000;66:1085–91.10.1177/000313480006601201Search in Google Scholar
25. Caty MG, Coran AG, Geagen M, Thompson NW. Current diagnosis and treatment of pheochromocytoma in children. Experience with 22 consecutive tumors in 14 patients. Arch Surg 1990;125:978–81.10.1001/archsurg.1990.01410200036004Search in Google Scholar PubMed
26. Mishra A, Mehrotra PK, Agarwal G, Agarwal A, Mishra SK. Pediatric and adolescent pheochromocytoma: clinical presentation and outcome of surgery. Indian Pediatr 2014;51:299–302.10.1007/s13312-014-0397-9Search in Google Scholar PubMed
©2017 Walter de Gruyter GmbH, Berlin/Boston
